Fook-Thean Lee

2.1k citations

29 papers · 991 indexed · h-index 19

Impact in

Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research

Papers in

Radiology, Nuclear Medicine and Imaging 15
- Monoclonal and Polyclonal Antibodies Research 11
- Radiopharmaceutical Chemistry and Applications 9
- Medical Imaging Techniques and Applications 3
Oncology 13
- HER2/EGFR in Cancer Research 6
- CAR-T cell therapy research 5
- Peptidase Inhibition and Analysis 3

Co-authors: Andrew M. Scott Anna Depaoli-Roach Stephen J. Yeaman Hui Gan Lloyd J. Old Sagun Parakh Fiona E. Smyth Martin W. Brechbiel
Journals: FEBS Letters (3 papers)Cancers (2 papers)Journal of Nuclear Medicine (2 papers)Clinical Cancer Research (2 papers)Theranostics (2 papers)
Partner nations: Australia United States Japan

In The Last Decade

Fook-Thean Lee

29 papers receiving 970 citations

Peers

Countries citing papers authored by Fook-Thean Lee

Since Specialization

Citations

This map shows the geographic impact of Fook-Thean Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fook-Thean Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fook-Thean Lee more than expected).

Fields of papers citing papers by Fook-Thean Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fook-Thean Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fook-Thean Lee. The network helps show where Fook-Thean Lee may publish in the future.

Co-authors

The 25 scholars most cited alongside Fook-Thean Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fook-Thean Lee Line = papers co-authored together Fook-Thean Lee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours Cancers ·Yew Ww, Mary E. Vail, Linda Hii, Madhur Sharma, Paul J. McMurrick, Karen Oliva, Simon Wilkins, Nayanendu Saha, Dimitar B. Nikolov, Fook-Thean Lee, Andrew M. Scott, Peter W. Janes	2022	7
2	Molecular imaging of T cell co-regulator factor B7-H3 with ⁸⁹Zr-DS-5573a Theranostics ·Ingrid J.G. Burvenich, Sagun Parakh, Fook-Thean Lee, Madhur Sharma, Zhanqi Liu, Hui Gan, Angela Rigopoulos, Graeme O’Keefe, Sylvia Gong, Nathaly Flores Chicaiza, Henri Tochon‐Danguy, Fiona E. Scott, Masakatsu Kotsuma, Kenji Hirotani, Giorgio Senaldi, Andrew M. Scott	2018	41
3	In Vitro and In Vivo Evaluation of ⁸⁹Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy Theranostics ·Ingrid J.G. Burvenich, Fook-Thean Lee, Madhur Sharma, Hui Gan, Angela Rigopoulos, Adam Parslow, Graeme O’Keefe, Sylvia Gong, Henri Tochon‐Danguy, Stacey E. Rudd, Paul S. Donnelly, Masakatsu Kotsuma, Toshiaki Ohtsuka, Giorgio Senaldi, Andrew M. Scott	2016	18
4	Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers EJNMMI Research ·Ingrid J.G. Burvenich, Fook-Thean Lee, Graeme O’Keefe, Eliza Fishman, Diana Cao, Sylvia Gong, Angela Rigopoulos, El-Said Fathy, Martin W. Brechbiel, Zhanqi Liu, Paul A. Ramsland, Andrew M. Scott	2016	15
5	Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with ⁸⁹Zr-DS-8895a Journal of Nuclear Medicine ·Ingrid J.G. Burvenich, Sagun Parakh, Hui Gan, Fook-Thean Lee, Madhur Sharma, Angela Rigopoulos, Sze-Ting Lee, Sylvia Gong, Graeme O’Keefe, Henri Tochon‐Danguy, Masakatsu Kotsuma, Jun Hasegawa, Giorgio Senaldi, Andrew M. Scott	2016	25
6	Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment Cancer Research ·Mary E. Vail, Carmel Murone, Veronika Chvátalová, Linda Hii, Jennifer Berglund, Peter W. Janes, Fook-Thean Lee, Mark Baer, P Sanwaria, Christopher Bebbington, Geoffrey Yarranton, A. J. Cuerda, I. G. Vilesova, David Abramson, Glenn A. Cartwright, Andrew M. Scott, Martin Lackmann	2014	67
7	Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of ¹³¹I-huA33 with Concurrent Capecitabine Journal of Nuclear Medicine ·Rebecca Herbertson, Niall C. Tebbutt, Fook-Thean Lee, Sanjeev Gill, Bridget Chappell, Janaína de Almeida Mesquita, Timothy Saunder, Graeme O’Keefe, Aurora Poon, Sze Ting Lee, Roger Murphy, Wendie Hopkins, Fiona E. Scott, Andrew M. Scott	2014	24
8	Quantitative intratumoural microdistribution and kinetics of 131I-huA33 antibody in patients with colorectal carcinoma EJNMMI Research ·Marika Ciprotti, Geoffrey Chong, Hui Gan, Anthony T.�C. Chan, Carmel Murone, Duncan MacGregor, Fook-Thean Lee, Terrance G. Johns, Joan K. Heath, Matthias Ernst, Antony W. Burgess, Andrew M. Scott	2014	9
9	Humanized Lewis-Y Specific Antibody Based Delivery of STAT3 siRNA ACS Chemical Biology ·Yuelong Ma, Claudia Kowolik, Piotr Swiderski, Marcin Kortylewski, Hua Yu, David Horne, Richard Jove, Otávia L. Caballero, Andrew J.G. Simpson, Fook-Thean Lee, Vinochani Pillay, Andrew M. Scott	2011	38
10	Internalization, Intracellular Trafficking, Biodistribution of Monoclonal Antibody 806: A Novel Anti-Epidermal Growth Factor Receptor Antibody Neoplasia ·Rushika M. Perera, Roberto Zoncu, Terrance G. Johns, Marc Pypaert, Fook-Thean Lee, Ira Mellman, Lloyd J. Old, Derek Toomre, Andrew M. Scott	2007	64
11	A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen Clinical Cancer Research ·Andrew M. Scott, Niall C. Tebbutt, Fook-Thean Lee, Janaína de Almeida Mesquita, Zhanqi Liu, Sanjeev Gill, Aurora Poon, Wendie Hopkins, Fiona E. Smyth, Carmel Murone, Duncan MacGregor, Anthony T. Papenfuss, Bridget Chappell, Timothy Saunder, Martin W. Brechbiel, Ian D. Davis, Roger Murphy, Geoffrey Chong, Eric W. Hoffman, Lloyd J. Old	2007	55
12	Concurrent Binding of Anti-EphA3 Antibody and Ephrin-A5 Amplifies EphA3 Signaling and Downstream Responses: Potential as EphA3-Specific Tumor-Targeting Reagents Cancer Research ·Christopher Vearing, Fook-Thean Lee, Sabine Wimmer-Kleikamp, Clark Higganbotham, Daniel J. Foreman, 薛继先, Mark Spanevello, Martin W. Brechbiel, Andy Boyd, Andrew M. Scott, Martin Lackmann	2005	63
13	Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model. PubMed ·M. Pampín, Fook-Thean Lee, S G Mahadevaiah, Pilar Garin‐Chesa, John E. Park, Fiona E. Smyth, Yuichi Obata, Elisabeth Stockert, Cathrine Hall, Lloyd J. Old, Wolfgang J. Rettig, Andrew M. Scott	2003	28
14	Immuno-PET for tumor targeting. PubMed ·Fook-Thean Lee, Andrew M. Scott	2003	25
15	PET imaging of (86)Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between (86)Y and (111)In radiolabels. PubMed ·Anna Lövqvist, John L. Humm, Arif Sheikh, R.D. Finn, Jacek Koziorowski, Shutian Ruan, Keith S. Pentlow, Achim A. Jungbluth, S Welt, Fook-Thean Lee, M W Brechbiel, Steven M. Larson	2001	75
16	In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice. PubMed ·Kerrie Clarke, Fook-Thean Lee, Martin W. Brechbiel, Fiona E. Smyth, Lloyd J. Old, Andrew M. Scott	2000	45
17	Hormone-sensitive lipase is involved in the hydrolysis of lipoidal derivatives of estrogens and other steroid hormones Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Fook-Thean Lee, John B. Adams, Andrew J. Garton, Stephen J. Yeaman	1988	50
18	Multiple phosphorylation of mouse muscle glycogen synthase Archives of Biochemistry and Biophysics ·Fook-Thean Lee, Y. NISHIKAWA, Anna Depaoli-Roach, Peter J. Roach	1987	4
19	Heparin-activated protein kinase from rabbit muscle: Relationship to enzymes of the glycogen synthase kinase-3 category Archives of Biochemistry and Biophysics ·Y. NISHIKAWA, Fook-Thean Lee, Anna Depaoli-Roach, Peter J. Roach	1986	15
20	Phosphoprotein phosphatase inhibitor‐2 is phosphorylated at both serine and threonine residues in mouse diaphragm FEBS Letters ·Anna Depaoli-Roach, Fook-Thean Lee	1985	79

About Fook-Thean Lee

Fook-Thean Lee is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Biochemistry, Immunology and Allergy and Cell Biology, having authored 29 papers that have together received 991 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), Radiopharmaceutical Chemistry and Applications (9 papers), HER2/EGFR in Cancer Research (6 papers), CAR-T cell therapy research (5 papers), Medical Imaging Techniques and Applications (3 papers), Lipid metabolism and biosynthesis (3 papers), Peptidase Inhibition and Analysis (3 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (400 citations), Oncology (341 citations), Biochemistry (50 citations), Cellular and Molecular Neuroscience (125 citations) and Cell Biology (109 citations). Fook-Thean Lee has collaborated with scholars based in Australia, United States and Japan. Frequent co-authors include Andrew M. Scott, Anna Depaoli-Roach, Stephen J. Yeaman, Hui Gan, Lloyd J. Old, Sagun Parakh, Fiona E. Smyth, Martin W. Brechbiel, Adam Parslow and Kenneth G. Cook. Their work appears in journals such as FEBS Letters, Cancers, Journal of Nuclear Medicine, Clinical Cancer Research and Theranostics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact